Steffen Lang
Chief Operating Officer en NOVARTIS AG .
Fortuna: 12 M $ al 31/03/2024
Perfil
Steffen Lang has held multiple positions in the pharmaceutical industry.
He is currently the Director at Bachem Holding AG since 2020 and the President-Operations at Novartis AG since 2017.
Dr. Lang has a graduate degree from Ruprecht-Karls-Universität Heidelberg and a doctorate degree from the Swiss Federal Institute of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NOVARTIS AG
0.01% | 31/12/2023 | 124 349 ( 0.01% ) | 12 M $ | 31/03/2024 |
| 31/12/2022 | 2 250 ( 0.00% ) | 215 832 $ | 31/03/2024 |
Cargos activos de Steffen Lang
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVARTIS AG | Chief Operating Officer | 04/04/2022 |
| BACHEM HOLDING AG | Director/Board Member | 22/04/2020 |
Formación de Steffen Lang.
| Ruprecht-Karls-Universität Heidelberg | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| BACHEM HOLDING AG | Health Technology |
- Bolsa de valores
- Insiders
- Steffen Lang
